Industry Considers Green-Chemistry Standards - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Industry Considers Green-Chemistry Standards


ePT--the Electronic Newsletter of Pharmaceutical Technology

An initiative to develop consensus-based industry standards to identify and define green chemicals and process technologies is underway. Robert Peoples, director of the American Chemical Society’s (ACS) Green Chemistry Institute, provided an update of the initiative Aug. 16 at the ACS National Meeting in Washington DC, according to an online article of Chemical and Engineering News (C&EN), an ACS publication. ACS is an organization representing chemists and professionals involved in the field of chemistry.

C&EN reported that nearly 50 stakeholders are helping to establish the green standard, which is expected to be completed in draft form for public comment by the end of this year. The aim is to have the standard certified by the American National Standards Institute (ANSI) in June 2010, according to the C&EN article. ANSI is a nonprofit association that functions as an administrator and coordinator of the US private-sector voluntary standardization system.

The standard will set criteria for chemical producers and users to evaluate the environmental impact and sustainability attributes of chemicals and their derivatives, according to the article. The ACS, chemical and pharmaceutical companies, the American Chemistry Council (which is the US-based trade association representing chemical manufacturers), nonprofit environmental organizations, and academia are participating in the process to develop the standard, according to C&EN.

The ACS Green Chemistry Institute focuses on promoting the understanding of green chemistry and green engineering. In 2005, the ACS Green Chemistry Institute and several major pharmaceutical companies developed the ACS GCI Pharmaceutical Roundtable to encourage the innovation and integration of green chemistry and green engineering in the pharmaceutical industry.

ADVERTISEMENT

post a comment
Your email address will NOT be published.
appears with your comment
read our privacy policy
Note: does not support HTML
All comments submitted are subject to review, and may be delayed before posting. We reserve the right not to post comments.
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What factor do you think will be most significant in 2010 for determining the health of the market for contract manufacturing of active pharmaceutical ingredients?
The global economic recovery
The US economic recovery
Improved credit and financing flow to the small to emerging pharma/bio sector
Less restrictive inventory control by pharmaceutical companies
The level of competition from contract manufacturers in emerging markets
The global economic recovery
40%
The US economic recovery
13%
Improved credit and financing flow to the small to emerging pharma/bio sector
15%
Less restrictive inventory control by pharmaceutical companies
8%
The level of competition from contract manufacturers in emerging markets
23%
View Results
Eric LangerOutsourcing OutlookEric Langer A Bio View of Outsourcing
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Advances in Custom Synthesis
Faiz kermaniSpotlightFaiz Kermani EU pricing dilemmas
Faiz kermaniStatistical Solutions Lynn Torbeck%RSD: Friend or Foe?
NSF, Microsoft Team in Cloud Computing
Keep an eye on that cargo
Pharma packs a punch
Another Boost for Vaccines
Rodney Dangerfield and R&D
FindPharma Custom Search
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here